Tamar Thompson
Director, Avidity Biosciences, Inc.
Companies
- Catalyst PharmaceuticalsBoard member Jun 5, 2023 to now1
- Avidity Biosciences, Inc.Board member Jan 11, 2021 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Catalyst Pharmaceuticals CPRX0 shares3Jul 15, 2026- Avidity Biosciences, Inc.0 shares4Feb 27, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 15, 2026Returned to company 3,773 shares at $31.50 of Catalyst Pharmaceuticals3
- Feb 27, 2026Returned to company 6,692 shares of Avidity Biosciences, Inc.4
- Dec 8, 2025Exercised options 1,413 shares of Catalyst Pharmaceuticals5
- Nov 21, 2025Exercised options 947 shares of Catalyst Pharmaceuticals6
- Jun 10, 2025Granted 6,692 shares of Avidity Biosciences, Inc.7
- Dec 9, 2024Exercised options 1,413 shares of Catalyst Pharmaceuticals8
- Oct 7, 2024Sold 30,000 shares at $44.98 of Avidity Biosciences, Inc.9
- Oct 7, 2024Exercised options 30,000 shares at $27.63 of Avidity Biosciences, Inc.9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Dec 10, 2025
- 6SEC EDGARForm 4 filed Nov 24, 2025
- 7SEC EDGARForm 4 filed Jun 12, 2025
- 8SEC EDGARForm 4 filed Dec 11, 2024
- 9SEC EDGARForm 4 filed Oct 9, 2024